ABRAXIS PHARMACEUTICAL PRODUCTS
Dead / Cancelled — Cancelled — Section 8 (as of 11 May 2018)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78865063
- Registration number
- 3309668
- Mark type
- Design + words
- Filed
- 19 Apr 2006
- Published for opposition
- 14 Nov 2006
- Registered
- 09 Oct 2007
- Attorney of record
- Camille M. Miller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace elements in the nature of mineral supplements for human consumption, vitamins, micronutrients, namely nutritional supplements, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; pharmaceuticals for treatment of cancer; pharmaceuticals to treat vascular diseases; drug delivery systems composed of nanoparticles sold as an integral component of drugs; injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases in the form of prefilled IV bags as a unit, sold separately or with devices for intravenous administration, namely transfer pins, vials, needles, adaptors and tamper resistant seals, sold as a kit
- Class 035 — Advertising and business services: distributorship and retail ordering services featuring pharmaceuticals, namely alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace elements, vitamins, micronutrients, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; distributorship and retail ordering services featuring pharmaceuticals for the treatment of cancer, pharmaceuticals to treat vascular diseases, drug delivery systems composed of nanoparticles sold as an integral component of drugs; distributorship and retail ordering services featuring IV bags for presentation with injectable drugs or therapeutic solutions and devices for intravenous administration of pharmaceuticals, namely transfer pins, vials, needles, pumping chamber sets, lubricants, adaptors and tamper resistant seals
Owner
- ABRAXIS BIOSCIENCE, LLC, Summit, NJ, US
- Abraxis BioScience, Inc., Los Angeles, CA, US
- Abraxis BioScience, Inc., Los Angeles, CA, US
- Abraxis BioScience, Inc., Los Angeles, CA, US
Prior registrations
Prosecution history
- 11 May 2018 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 09 Oct 2016 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 25 Jan 2016 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Jan 2016 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 27 Jul 2015 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 31 Oct 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Oct 2012 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 31 Oct 2012 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Oct 2012 — TEAS SECTION 8 & 15 RECEIVED
- 15 Oct 2010 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Oct 2010 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Dec 2007 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Oct 2007 — REGISTERED-PRINCIPAL REGISTER
- 06 Sept 2007 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 06 Sept 2007 — ASSIGNED TO LIE